Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile

Int J Antimicrob Agents. 2002 Aug;20(2):108-12. doi: 10.1016/s0924-8579(02)00122-x.

Abstract

The mechanism of resistance was investigated in 39 macrolide-resistant clinical isolates of Streptococcus pneumoniae isolated from January 1997 to July 1999 in Santiago, Chile. Our results showed that 22 (56.5%) were macrolide-resistant, clindamycin-susceptible isolates (M phenotype) and 17 (43.5%) were macrolide and clindamycin resistant (MLS(B) phenotype). mefE gene was detected in all M phenotype, while ermB gene was detected in all MLS(B)-phenotype strains. Serotype 14 was the most frequent serotype among M-phenotype strains, and serotypes 19 and 23F were the most frequent serotypes in MLS(B) strains. These results demonstrate that both phenotypes of macrolide-resistant S. pneumoniae are found in Santiago, Chile, with the M phenotype predominating.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Child
  • Chile
  • Clindamycin / pharmacology
  • Drug Resistance, Bacterial* / genetics
  • Erythromycin / pharmacology*
  • Humans
  • Membrane Proteins*
  • Methyltransferases / genetics
  • Microbial Sensitivity Tests
  • Phenotype
  • Serotyping
  • Streptococcus pneumoniae / classification
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / genetics

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • MefE protein, Streptococcus pneumoniae
  • Membrane Proteins
  • Clindamycin
  • Erythromycin
  • Methyltransferases
  • rRNA (adenosine-O-2'-)methyltransferase